🏥 Medical Tourism Blog

Expert guides, cost comparisons, and patient stories to help you make informed decisions about healthcare in China

📖 The Complete Guide to Medical Tourism in China

9 chapters. Everything from hospital selection to recovery at home. Free.

Read the Guide →

Browse by Topic

🌟 Featured: What Only China Can Do

Medical procedures you can only get in China — or get dramatically cheaper, faster, and at higher volume than anywhere else.

🏥 10 Procedures China Leads
From CAR-T to autonomous robotic surgery — see the full list.
🌿 Integrated Chinese-Western Medicine
The exclusive model — acupuncture, herbal, Western combined.
🧬 Solid Tumor CAR-T
World's first — satri-cel approved June 2026.
🤖 Autonomous Robotic Surgery
World's first autonomous dental implant, AFMU Xi'an 2017.

🎯 Browse by What Makes China Different

Three categories where China is genuinely ahead of the world — not just cheaper.

🌿 Traditional Chinese Medicine (TCM)

Acupuncture, herbal medicine, moxibustion, cupping, baduanjin — proven in clinical trials, integrated with Western care at top hospitals.

🧬 Frontier Medicine (CAR-T, Stem Cell, CRISPR)

7 approved CAR-T therapies (more than US/EU), world's largest CRISPR pipeline, broader stem cell access through Boao Lecheng.

🏆 World's-Best Volume Specialties

Ophthalmology, orthopedics, cardiac surgery, microsurgery, IVF — where Chinese hospitals do the most cases in the world.

Latest Articles

When the Plan Breaks: Nine Things That Go Wrong on a Medical Trip to China
Troubleshooting

When the Plan Breaks: Nine Things That Go Wrong on a Medical Trip to China

A step-by-step troubleshooting guide for foreign patients in China — what fails at each stage, why it happens, and the specific action that recovers it.

November 202611 min read
Read Article →
A Pancreatic Tumour Wrapped Around the Splenic Vein: Inside the Tangdu Spleen-Preserving Procedure
Pancreatic Surgery

A Pancreatic Tumour Wrapped Around the Splenic Vein: Inside the Tangdu Spleen-Preserving Procedure

When a pancreatic body tumour encases the splenic vein, standard spleen-preserving surgery may not be possible. A Xi'an team describes a third route — and names it.

November 20269 min read
Read Article →
CO₂ Angiography in China: Stenting When Iodine Contrast Is Off the Table
Vascular Care

CO₂ Angiography in China: Stenting When Iodine Contrast Is Off the Table

If low kidney function or an iodine allergy rules out standard angiography, carbon dioxide angiography may be the way in. What Chinese vascular centres actually do, where CO₂ stops working, and what to send first.

November 202610 min read
Read Article →
Hair Transplant in China 2026: What Decides Whether the Result Looks Natural
Hair Restoration

Hair Transplant in China 2026: What Decides Whether the Result Looks Natural

Graft survival, donor planning, hairline design and who does the work decide a hair transplant result — not the technique's brand name. A quality-first guide for China.

October 20269 min read
Read Article →
A 45-Gram Artificial Heart Ran for 485 Days in an 8-Year-Old Boy
Pediatric Cardiology

A 45-Gram Artificial Heart Ran for 485 Days in an 8-Year-Old Boy

Wuhan's Union Hospital says a child lived 485 days on a fully magnetically levitated biventricular pump before receiving a donor heart. What the hospital claimed, and what has not been verified.

October 20266 min read
Read Article →
Medical Qigong in China 2026: Inside the Only Government-Run Qigong Hospital
TCM & Wellness

Medical Qigong in China 2026: Inside the Only Government-Run Qigong Hospital

A public hospital in Beidaihe has been treating patients with qigong since the 1950s. What it is, what it is not, and who it is actually for.

October 202610 min read
Read Article →
Weight-Loss Drugs in China 2026: What the Phase III Data Show, the China-First Drug, and What They Cost
Metabolic Medicine

Weight-Loss Drugs in China 2026: What the Phase III Data Show, the China-First Drug, and What They Cost

China's obesity drug candidates now report around 19% weight loss in Phase III. The 2026 data, tolerability, the China-first mazdutide, and what treatment costs.

October 20269 min read
Read Article →
Weight-Loss Surgery in China 2026: Sleeve, Bypass or Mini-Bypass — How the Choice Is Actually Made
Bariatric Surgery

Weight-Loss Surgery in China 2026: Sleeve, Bypass or Mini-Bypass — How the Choice Is Actually Made

Weight-loss surgery in China: how surgeons choose between sleeve gastrectomy, gastric bypass and mini-bypass, what each costs, and what happens after.

September 20268 min read
Read Article →
Pluvicto in China 2026: Cost, Eligibility & Access for International Patients
Oncology

Pluvicto in China 2026: Cost, Eligibility & Access for International Patients

Pluvicto is licensed in China — the only PSMA-targeted radioligand therapy approved here. What it costs, who qualifies, and the path from PSMA PET scan to first infusion.

September 202611 min read
Read Article →
Colorectal Cancer Treatment in China 2026: Surgery, Chemoradiation or a Stoma — How the Tumour's Address Decides
Oncology

Colorectal Cancer Treatment in China 2026: Surgery, Chemoradiation or a Stoma — How the Tumour's Address Decides

Colorectal cancer in China: colectomy for colon cancer, chemoradiation before surgery for rectal cancer, and when a permanent stoma is unavoidable. Costs, hospitals, and what the tests decide.

September 20269 min read
Read Article →
Heart Valve Disease Treatment in China 2026: Repair, Replacement or TAVR — How the Choice Is Made, and What It Costs
Cardiology

Heart Valve Disease Treatment in China 2026: Repair, Replacement or TAVR — How the Choice Is Made, and What It Costs

Heart valve disease in China: repair vs replacement, mechanical vs biological valves, and open surgery vs TAVR. Costs, hospitals, and how the choice is made.

September 20268 min read
Read Article →
Stomach Cancer Treatment in China 2026: Surgery, Perioperative Chemotherapy or Systemic Therapy — How Stage Decides
Oncology

Stomach Cancer Treatment in China 2026: Surgery, Perioperative Chemotherapy or Systemic Therapy — How Stage Decides

Stomach cancer treatment in China: partial or total gastrectomy, perioperative chemotherapy, and systemic therapy by stage. Costs, hospitals, and how the plan is set.

September 20269 min read
Read Article →
Stroke Rehabilitation in China 2026: Why the First Six Months Decide the Outcome, and What a Programme Costs
Neurology

Stroke Rehabilitation in China 2026: Why the First Six Months Decide the Outcome, and What a Programme Costs

Stroke rehabilitation in China: why the first three to six months matter most, what an inpatient programme involves, where TCM fits, and what it costs.

September 20269 min read
Read Article →
Breast Cancer Treatment in China 2026: Surgery, Reconstruction or Systemic Therapy — How Stage and Subtype Decide
Oncology

Breast Cancer Treatment in China 2026: Surgery, Reconstruction or Systemic Therapy — How Stage and Subtype Decide

Breast cancer treatment in China: surgery and reconstruction for early stage, neoadjuvant therapy for locally advanced. Costs, hospitals, and how subtype decides.

September 20269 min read
Read Article →
Dendritic Cell Therapy in China 2026: What's Legal, Who Can Get It
Cellular Immunotherapy

Dendritic Cell Therapy in China 2026: What's Legal, Who Can Get It

DC therapy is not routine care in mainland China. The only two legal routes, the 2026 rule changes, and how to spot a clinic selling a cure.

September 20269 min read
Read Article →
Cervical Cancer Treatment in China 2026: Surgery, Chemoradiation or Brachytherapy — How Staging Decides, and What It Costs
Oncology

Cervical Cancer Treatment in China 2026: Surgery, Chemoradiation or Brachytherapy — How Staging Decides, and What It Costs

Cervical cancer in China: surgery for early stage, chemoradiation plus brachytherapy for locally advanced disease. Costs, top hospitals, and the staging path.

September 20268 min read
Read Article →
Advanced Heart Failure Treatment in China 2026: CRT, ICD, LVAD or Transplant — How to Know Which One You Need
Heart Failure

Advanced Heart Failure Treatment in China 2026: CRT, ICD, LVAD or Transplant — How to Know Which One You Need

Low EF (≤35%) and refractory heart failure: how doctors choose CRT, ICD, CCM, CABG, valve repair, LVAD or transplant — costs and the decision path.

September 20269 min read
Read Article →
Choosing a Hospital in China You Can't Visit: How China Hospitals Guide Works (and What's New in 2026)
How We Work

Choosing a Hospital in China You Can't Visit: How China Hospitals Guide Works (and What's New in 2026)

Independent matching, a free cost calculator, 52 verified hospital pages, three service tiers — how we help you choose a hospital in China.

September 20268 min read
Read Article →
Foreigners Are Coming to China for Cancer Treatment: Inside the ¥990,000 CAR-T Shot and a Booming Market
Medical Tourism

Foreigners Are Coming to China for Cancer Treatment: Inside the ¥990,000 CAR-T Shot and a Booming Market

1.28 million international patients, CAR-T at a third of US prices, 48-hour workups. Why foreigners fly to China for cancer care in 2026 — data, real cases, costs.

September 202610 min read
Read Article →
World's First International Patient Treated with Solid-Tumor CAR-T in China: The Satri-cel (CLDN18.2) Case
Cell Therapy

World's First International Patient Treated with Solid-Tumor CAR-T in China: The Satri-cel (CLDN18.2) Case

A New Zealand man became the first international patient to complete satri-cel, China's world-first solid-tumor CAR-T. The real case, timeline, and how to apply.

August 20269 min read
Read Article →
China Hospeq 2026 Medical Device Expo: 40,000㎡, 500+ Exhibitors and What It Means for International Patients
Medical Technology

China Hospeq 2026 Medical Device Expo: 40,000㎡, 500+ Exhibitors and What It Means for International Patients

China's flagship device expo wrapped in Beijing: surgical robotics, AI diagnostics, high-end imaging — and why made-in-China technology keeps treatment affordable.

August 20268 min read
Read Article →
World's First CAR-T for Gastric Cancer: Satri-cel (CLDN18.2) in China — Trial Data, Eligibility & Risks
Oncology

World's First CAR-T for Gastric Cancer: Satri-cel (CLDN18.2) in China — Trial Data, Eligibility & Risks

The world's first solid-tumor CAR-T targets CLDN18.2 in advanced gastric cancer. Lancet CT041-ST-01 data, who qualifies, the real risks, and how to apply in China.

August 202612 min read
Read Article →
Oncolytic Virus Therapy in China: H101 (Ankerui) Turns 'Cold' Tumors Hot
Oncology

Oncolytic Virus Therapy in China: H101 (Ankerui) Turns 'Cold' Tumors Hot

China's only NMPA-approved oncolytic virus fights cold tumors: how the engineered adenovirus works, ASCO 2024 evidence, safety, and how international patients can access it.

August 202611 min read
Read Article →
CAR-T Therapy for Multiple Myeloma in China 2026: $89K-$151K, Top Hospitals & How to Get Treatment
Oncology

CAR-T Therapy for Multiple Myeloma in China 2026: $89K-$151K, Top Hospitals & How to Get Treatment

BCMA CAR-T for relapsed/refractory multiple myeloma in China: $89K-$151K commercial, $30K-$80K trials. Approved products, top hospitals, waiting time — 2026 guide.

August 202611 min read
Read Article →
Chinese 3D-Printed Implant Rebuilds a Pelvis After Bone Cancer: The Lahore Case and How to Get Custom Implant Surgery in China
Orthopedics

Chinese 3D-Printed Implant Rebuilds a Pelvis After Bone Cancer: The Lahore Case and How to Get Custom Implant Surgery in China

A Lahore hospital rebuilt a 26-year-old's hip with a Chinese 3D-printed pelvic implant after chondrosarcoma. Why China leads custom implant surgery — and how international patients access it.

August 20268 min read
Read Article →
China Supplies 30% of Indonesia's Herbal Medicine Imports: New BPOM-NMPA Pact Speeds CAR-T and TCM Access
Medical Tourism

China Supplies 30% of Indonesia's Herbal Medicine Imports: New BPOM-NMPA Pact Speeds CAR-T and TCM Access

Indonesia's BPOM and China's NMPA are renewing their drug-regulation MoU, covering CAR-T (ATMP), clinical trials and traditional medicine. What this means for Indonesian patients heading to China.

August 202610 min read
Read Article →
China's 10-Minute Brain Implant: Vein-Based BCI Without Skull Surgery, and the World's First Approved Device Is Already Here
Medical Innovation

China's 10-Minute Brain Implant: Vein-Based BCI Without Skull Surgery, and the World's First Approved Device Is Already Here

Shanghai startup StairMed unveiled a vein-based brain implant that could be placed in 10 minutes, while China already holds the world's first approved invasive BCI. What international patients should know.

August 20268 min read
Read Article →
China Approves the World's First Drug for FGFR2-Resistant Bile Duct Cancer: 28% Response Rate, 8.5-Month Duration
Oncology

China Approves the World's First Drug for FGFR2-Resistant Bile Duct Cancer: 28% Response Rate, 8.5-Month Duration

NMPA cleared TransThera's tinengotinib (Yochanra) for bile duct cancer that stopped responding to FGFR inhibitors — a world first, with 28% ORR and an 8.5-month median duration of response from the FIRST-08 trial.

August 20268 min read
Read Article →
China Clears a New Immunotherapy for 'Cold' Colorectal Cancer: PD-L1 × 4-1BB Bispecific Gets IND for MSS/pMMR mCRC
Oncology

China Clears a New Immunotherapy for 'Cold' Colorectal Cancer: PD-L1 × 4-1BB Bispecific Gets IND for MSS/pMMR mCRC

China approved Leads Biolabs' Opamtistomig (LBL-024) PD-L1 × 4-1BB bispecific for combination trials in MSS/pMMR metastatic colorectal cancer — the 95% of CRC patients who do not respond to standard checkpoint inhibitors.

August 20268 min read
Read Article →
Boao Lecheng Passes 600 First-in-China Therapies: Korean Aesthetic Hospital + TCM Wellness Now Open to International Patients
Medical Tourism

Boao Lecheng Passes 600 First-in-China Therapies: Korean Aesthetic Hospital + TCM Wellness Now Open to International Patients

Hainan's Boao Lecheng pilot zone now offers 600+ drugs, devices and therapies approved for the first time in China, added a Korean aesthetic hospital, and runs TCM wellness programs. Here is what international patients can access.

August 20268 min read
Read Article →
← Back to Home Diagnostic page

Planning treatment in China?

Start with a free case review and get guidance on the right hospital and package for your situation.

Start Free Case Review
🏠Home 💰Pricing 📧Email 💬WhatsApp 📨Telegram
📧Email us 💬Chat on WhatsApp 📨Chat on Telegram 💬WeChat: chinahospitalguide
🏥

Before You Go...

Finding the right hospital in China can be overwhelming. Let us help — free, no commitment.

⏳ Most cases get a hospital match within 24 hours

Start Free Case Review
No thanks, I'll keep searching